- Treatment possiblities of multiple sclerosis in children and adolescents2019 | Faculty of Medicine in Pilsen
- Therapy of rheumatoid arthritis with synthetic and biological disease modifying drugs.2009 | First Faculty of Medicine
- Adverse Events of Drugs Used in Therapy or Rheumatic diseases - I. Disease Modifying drugs Used in the Therapy of Rheumatoid Arthritis and Basic Principals of Monitoring of Safety2003 | First Faculty of Medicine
- Multiple sclerosis - early diagnosis and treatment options2019 | First Faculty of Medicine
- Prevention of surgical Joint Replacement in the Long-term follow-up of Recent Disease-modifying Drug Trials in OsteoarthritisPublication without faculty affiliation
- Multiple sclerosis2008 | First Faculty of Medicine
- Immunogenicity and safety of the booster BNT162b2 vaccine in patients with axial spondyloarthritis treated with biological disease-modifying drugs2022 | Second Faculty of Medicine
- Methotrexate and its role in rheumatology daily practice2019 | First Faculty of Medicine
- Multiple Sclerosis and Microbiome2022 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Natalizumab2007 | First Faculty of Medicine
- Pregnancy and multiple sclerosis from a neurologist's point of view2018 | First Faculty of Medicine, Second Faculty of Medicine
- Care for a pregnant woman with multiple sclerosis2019 | Faculty of Medicine in Pilsen
- Analysis of the Group of Pediatric Patients With Relapsing-Remitting Multiple Sclerosis: Data From the Czech National Registry2022 | Second Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine
- The importance of subcutaneous methotrexate in the treatment of rheumatic diseases2015 | First Faculty of Medicine
- The introduction of new medications in pediatric multiple sclerosis: Open issues and challenges2021 | First Faculty of Medicine
- Rheumatoid arthritis and kidney disease2020 | First Faculty of Medicine
- Initiation of first disease-modifying treatment for multiple sclerosis patients in the Czech republic from 2013 to 2016: Data from the national registry ReMuS2019 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové, Central Library of Charles University, Faculty of Medicine in Pilsen, Third Faculty of Medicine
- Shortening the washout to 4 weeks when switching from natalizumab to fingolimod and risk of disease reactivation in multiple sclerosis2018 | First Faculty of Medicine
- Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice2017 | First Faculty of Medicine
- Recommendations of Czech Rheumatological Association for the treatment of rheumatoid arthritis. Efficacy and treatment strategies.2008 | First Faculty of Medicine
- News in the treatment of inflammatory arthropathies for general practitioners2019 | First Faculty of Medicine
- Dimethyl-fumarate in treating relapsing-remitting multiple sclerosis +12014 | Second Faculty of Medicine
- Dimethyl fumarate in treating relapsing-remittin multiple sclerosis2015 | First Faculty of Medicine, Second Faculty of Medicine
- Pharmacotherapy of inflammatory rheumatic disease.2008 | First Faculty of Medicine
- Main principles of pharmacotherapy of rheumatic diseases in old age2019 | First Faculty of Medicine
- Progressive multiple sclerosis in the light of the latest findings2023 | First Faculty of Medicine
- Interferon, azathioprine and corticosteroids in multiple sclerosis: 6-year follow-up of the ASA cohort2012 | First Faculty of Medicine
- Optimizing outcomes in rheumatoid arthritis patients with inadequate responses to disease-modifying anti-rheumatic drugs2012 | First Faculty of Medicine
- The treatment of patient with relapsing-remitting multiple sclerosis2017 | Faculty of Medicine in Hradec Králové